Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Cornea ; 37(7): 886-892, 2018 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-29377842

RESUMO

PURPOSE: To evaluate the effect of lipid- versus sodium hyaluronate-based eye drops on optical quality and ocular surface parameters. METHODS: Sixty eyes of 30 patients with mild-to-moderate dry eye disease were included in a prospective randomized study. Each patient received either lipid- or sodium hyaluronate-based eye drops. Ocular symptom scores, breakup time, Schirmer test, fluorescein staining, noncontact meibography, and aberrometry were evaluated before and after 3 months of therapy. RESULTS: At the 3-month visit, a statistically significant improvement (P ≤ 0.05) was noted in both groups on the Schirmer test, breakup time, ocular surface staining, and symptom score. In the lipid group, patients with progressive meibomian gland (MG) loss (>50%) showed a significantly greater increase in their corneal higher-order (HO) Strehl ratio (0.25 ± 0.26 vs. -0.01 ± 0.25, P = 0.02) and modulation transfer function (MTF) (0.12 ± 0.17 vs. -0.02 ± 0.06, P = 0.03) than patients with less advanced MG disease. In the lipid group, a significant positive correlation was noted between the MG dropout rate and improvement in Schirmer values [Spearman correlation coefficient (CC): 0.79], corneal HO Strehl (CC: 0.75), and HO modulation transfer function (CC: 0.6), but a significant negative correlation was noted between the MG dropout rate and the HO root mean square (CC: -0.73). CONCLUSIONS: Lipid-containing artificial tears seem to be superior to sodium hyaluronate-containing drops in terms of improving HO aberrations and optical quality in patients with significant MG dysfunction.


Assuntos
Córnea/patologia , Síndromes do Olho Seco/tratamento farmacológico , Ácido Hialurônico/uso terapêutico , Lipídeos/uso terapêutico , Lubrificantes Oftálmicos/uso terapêutico , Glândulas Tarsais/patologia , Aberrometria , Adulto , Idoso , Idoso de 80 Anos ou mais , Síndromes do Olho Seco/fisiopatologia , Feminino , Humanos , Ácido Hialurônico/farmacologia , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Lágrimas/metabolismo
2.
J Ophthalmol ; 2017: 1946527, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28791180

RESUMO

PURPOSE: Popular beliefs exert an impact of lunar phases on elective surgery. The aim of our study was to evaluate potential correlations between complications in cataract surgery and the phases of the moon during its passage through the zodiac and Fridays that fall on the 13th. METHODS: Patients with complications during cataract surgery were extracted retrospectively from the clinical database from 2010 to 2014. The dates of surgeries were viewed in relation to the phase and the position of the moon (sign of the zodiac). RESULTS: Of 16,965 cataract surgeries, 132 eyes developed complications. 0.70% developed complications with a waxing moon, and 0.87% with a waning moon (p = 0.745). After Bonferroni correction, there were no statistically significant differences between the numbers of complications under the different signs of the zodiac and no complications on Fridays that fell on the 13th. CONCLUSIONS: The analysis of "non-moon-fitting days" for surgery showed quantitative differences, without statistically significant findings. Our results revealed more complications when the moon was waning, which is in contrast to esoteric belief. Patients may be informed that phases of the moon, signs of the zodiac, or a particular date will have no impact on their surgeries.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA